其 他 安 全 警 示
|
| |
| The United Kingdom: Class 4 Medicines Defect Information: Advanz Pharma Zapain 30mg／500mg Tablets (Codeine Phosphate ／Paracetamol) (English only) |
| |
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Advanz Pharma has informed MHRA of a discrepancy on the product packaging for 63 batches of Zapain 30mg/500mg Tablets (Codeine Phosphate/Paracetamol). The discrepancy relates to “capsules” printed at the top right of the packs in error (where this should be tablets). The other product details on the packs including the name, strength and pharmaceutical form of the medicine are correct. Please refer to the website in MHRA for details of the affected batches.
Healthcare professionals are advised to exercise caution when dispensing the product. There is no risk to product quality as a result of this issue, therefore the associated batches are not being recalled at this time.
Please refer to the following website in MHRA for details:
http://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-advanz-pharma-zapain-30mg-500mg-tablets-codeine-phosphate-paracetamol-pl12762-0034-el-20-a-01
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Wednesday, Jan 15, 2020
Issued at HKT 15:00
|
| |
